(b)(4).
Investigation/evaluation: during the course of the investigation, a review of the complaint history, device history record, instructions for use (ifu), and documentation of the product was conducted.
The complaint device was not returned.
Therefore, no physical examinations could be performed.
However, a document based investigation evaluation was performed.
There is no evidence to suggest the product was not made to specifications.
At this time the device appears to not have a malfunction related for this event; occur due to the procedure error.
Our instructions for use (ifu) notates for its intended use, " continuous or intermittent drug infusions, central venous blood pressure monitoring (cvp), acute hyperalimentation, blood sampling, delivery of whole blood or blood products, and power injection of contrast media.
" the device is shipped with an ifu that describes the intended use contraindications, warnings and precautions, and the correct deployment procedure.
The ifu indicates the ¿device is a short-term use catheter¿ every effort must be made to ascertain proper tip position in order to prevent erosion or perforation of central venous system.
Tip position should be verified by x-ray and monitored on a routine basis.
Periodic lateral view x-ray is suggested to assess tip location in relation to vessel wall.
Tip position should appear to be parallel to the vessel wall¿patient movement can cause catheter tip displacement.
Use should be limited to controlled hospital situations.
Use of ecg, ultrasound and/or fluoroscopy is suggested for accurate catheter placement.
" we will continue to monitor for similar complaints and have notified the appropriate internal personnel.
Per the risk assessment,no further action is required.
|